Navigation Links
Hagens Berman Sobol Shapiro Announces Investigation Into Marketing of Vytorin and Zetia
Date:1/16/2008

ded to prove the claim and show a correlation between lowered LDL levels and fatty plaques in the arteries, which can cause heart attacks and strokes, according to published documents.

The investigation centers on allegations that while the study once again showed that Vytorin lowered LDL cholesterol rates better than Zocor alone, it also showed that the fatty arterial plaques actually grew somewhat faster in patients taking Zetia along with Zocor than in those taking Zocor alone.

The investigation is also looking into questions regarding the timing of the study's release. According to published reports, the two-year drug trial concluded April 2006 but wasn't announced until January 15, 2008. Reports also suggest Merck and Schering-Plough knew the results of the trials but delayed sharing the findings with patients and did not change its marketing approach.

Zetia and Vytorin account for combined sales of $1.1 billion during the fourth quarter of 2007. The agreement with Merck and Schering-Plough provided that the companies split profits roughly 50-50, depending on regions.

The investigation is examining remedies for patients, including the possibility of legal action seeking the return of money to purchasers of Vytorin and Zetia, which the study shows are no more effective than the generic form of Zocor.

If you are a Vytorin or Zetia patient and would like more information about the investigation, please visit http://www.hbsslaw.com/zetia.htm or e-mail info@hbsslaw.com.

About Hagens Berman Sobol Shapiro

Hagens Berman Sobol Shapiro is based in Seattle with offices in Chicago, Cambridge, Los Angeles, Phoenix and San Francisco. Since 1993, it has developed a nationally recognized practice in class-action and complex litigation. Among recent successes, HBSS has negotiated a $300 million settlement in the DRAM memory antitrus
'/>"/>

SOURCE Hagens Berman Sobol Shapiro
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Hagens Berman Sobol Shapiro: Judge Orders Double Damages, Issues Stinging Rebuke in Average Wholesale Price Case
2. Rulings Send Lawsuits Against State Farm, American Family Back to Court, Hagens Berman Sobol Shapiro Announces
3. Universal Health Services, Inc. Announces Dividend
4. BD Announces Webcast of Annual Meeting of Shareholders
5. STERIS Corporation Announces Date of Fiscal 2008 Third Quarter Earnings Release and Conference Call
6. Chem Rx Announces the Appointment of Three New Directors
7. Brighton Hospital Announces Creation of Brighton National Addiction Foundation
8. PreMD Announces FDA Decision on POC Skin Cholesterol Test
9. Virginia Cares Uninsured Program (VCUP) Announces Early Successes in Helping Uninsured Virginians Access Quality Healthcare
10. Caris Diagnostics Announces Addition of Leading Dermatopathologist to Expand Subspecialty Expertise
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Metaglip(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... California (PRWEB) March 02, 2015 Final ... of the TranStatic Volume 2 from Pixel Film Studios. , ... made exclusively for FCPX,” said Christina Austin, CEO of Pixel ... have in any Final Cut Pro X editors toolbox.” , ... to the next with media altering static scrambling effects from ...
(Date:3/1/2015)... Women’s Excellence is pleased to announce ... on their website. There are over 75 terms and phrases ... , “This gives our patients a better understanding of what ... they may not understand. With this resource, our patients are ... and find terms and phrases that they may not remember or ...
(Date:3/1/2015)... March 01, 2015 A federal ... http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) scheduled to go to trial in ... a witness to provide testimony regarding the role ... of the Profemur device, Bernstein Liebhard LLP comments. ... Court, Northern District of Iowa on February 25th, ...
(Date:3/1/2015)... “ The Barrel Mill ” was featured ... takes a look at the latest and coolest technology products ... NewsWatch and a technology expert, conducted the review and shared ... drinks. , According to Home Distillation of Alcohol, it's understood ... there’s a pretty cool product that’ll help anyone achieve a ...
(Date:2/28/2015)... Heart diseases are on the rise in India. ... population and 5 percent of rural adult population suffer ... of them require specialized investigation and treatment to prevent ... (CVD). , A division of Indian Business News Agency ... “Indian Coronary Stent Market Forecast to 2019”. The new ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 3Health News:An Oak Infusion Spiral was Featured on NewsWatch Television on January 30, 2015 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3
... ... weight loss can be with HCG Diet Drops , ... (PRWEB) June 14, 2010 -- It is no secret that obesity has reached epidemic ... suffering from health problems as a result of the extra pounds. , , ,But thanks ...
... CerMedia ... the Cell-Pore product group previously owned and operated by NanoDynamics, Inc. ... Buffalo, NY (PRWEB) ... of the principal manufacturing and production assets, inventory and certain information of the Cell-Pore ...
... ... specialist in cosmetic, facial plastic, and reconstructive surgery, understands that women need options. With ... patients an alternative method to breast implant surgery. Natural breast augmentation allows patients the ... ...
... N.C. Monday, June 14, 2010 A new study ... shows that millions of cancer survivors are forgoing needed medical ... today in CANCER, a peer-reviewed journal of the ... long-term health and well-being of cancer survivors could suffer because ...
... ... medical and financial benefits. The Sit&SipTM bottle is engineered for easy and healthy performance. ... ... 15 - 20 million visits to the doctor each year in the U.S. Acute ...
... ... , ... The Primax Electronic Cigarette System is now available from Primevapor.com., , ,Primevapor has combined a ... These cartridges not only produce more flavor and more vapor, but use US manufactured, vegetable ...
Cached Medicine News:Health News:Thousands Drop The Weight For Good with HCG Diet Drops 2Health News:CerMedia Completes Purchase of Cell-Pore Principal Assets from NanoDynamics 2Health News:Del Mar Plastic Surgeon Dr. Maurice Sherman Now Offering Natural Breast Implant Alternatives 2Health News:Cost concerns prevent many cancer survivors from getting medical care 2Health News:Ear Infection is the Most Common Reason Why an American Child Sees the Doctor 2Health News:Ear Infection is the Most Common Reason Why an American Child Sees the Doctor 3Health News:Electronic Cigarettes Are Better Than Ever 2
(Date:3/2/2015)... Calif. , March 2, 2015 Isis Pharmaceuticals, ... has earned a $15 million milestone payment from GSK related ... in patients with familial amyloid polyneuropathy (FAP).  ... with ISIS-TTR Rx , and plan to report data from ... have completed the fifteen months of dosing and are now ...
(Date:3/2/2015)... BETHESDA, Md. , March 2, 2015 ... on treating and preventing autoimmune diseases, announced today that ... (AMG 714) from Amgen (NASDAQ: AMGN ). ... has the rights to develop, manufacture and commercialize AMG ... . Concurrently, Amgen has been granted an exclusive ...
(Date:3/2/2015)... Texas , March 2, 2015   Lexicon ... biopharmaceutical company focused on developing breakthrough treatments for human ... 2014 financial results on Wednesday, March 4, 2015 before ... conference call and webcast to discuss clinical development progress ... end of 2014 at 10:00 a.m. Eastern Time on ...
Breaking Medicine Technology:Isis Pharmaceuticals Earns $15 Million From GSK for Advancing ISIS-TTR Rx 2Isis Pharmaceuticals Earns $15 Million From GSK for Advancing ISIS-TTR Rx 3Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen 2Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen 3Lexicon To Report Fourth Quarter And Year End 2014 Financial Results On March 4, 2015 2
... plc (Nasdaq: JAZZ ) today announced several ... company,s leadership team. The appointments include: ... company and will serve as general counsel and an ... in March.  Ms. Hooper is currently a partner at ...
... Sinovac Biotech Ltd. (Nasdaq: SVA ), a leading ... a letter dated January 18, 2012 from The Nasdaq Stock ... from the Company,s Board of Directors effective January 4, 2012, ... Nasdaq,s requirement that its audit committee consists of at least ...
Cached Medicine Technology:Jazz Pharmaceuticals plc Announces New Executive Appointments 2Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee Requirement 2
The VPAP III is a complete system solution for sleep-disordered breathing (SDB), providing comfortable and effective bilevel treatment. The VPAP III is an effective business solution for clinicians, ...
... for the Separation and Measurement of ... Subfractions, ,The Lipoprint System is a ... components which are not routinely tested ... provides detailed results within the subfractions ...
... high resolution diagnostic test for cholesterol components which ... test procedure is simple and can be done ... is clearly flagged. A color coded profile is ... in red and the good HDL in green. ...
... Ammonia/Alcohol Control is intended as ... ammonia and ethanol assay methods. ... targeted at clinically significant levels ... values are provided for the ...
Medicine Products: